Published: Guidance, quality standards and advice
Showing 41 to 50 of 2559
| Title | Reference number | Published | Last updated |
|---|---|---|---|
| Pegzilarginase for treating arginase-1 deficiency in people 2 years and over | HST35 | ||
| Durvalumab with gemcitabine and cisplatin for neoadjuvant treatment then alone for adjuvant treatment of muscle-invasive bladder cancer | TA1138 | ||
| Rare diseases | QS214 | ||
| Blood transfusion | QS138 | ||
| Molnupiravir for treating COVID-19 | TA1056 | ||
| Nirmatrelvir plus ritonavir and tocilizumab for treating COVID-19 | TA878 | ||
| Hypertension in adults: diagnosis and management | NG136 | ||
| Blood transfusion | NG24 | ||
| Leadless cardiac pacemaker implantation for bradyarrhythmias | HTG770 | ||
| Transcatheter tricuspid valve implantation for symptomatic severe tricuspid regurgitation | HTG771 |